DZ2302A1 - Produit pharmaceutique cristallin. - Google Patents

Produit pharmaceutique cristallin.

Info

Publication number
DZ2302A1
DZ2302A1 DZ970152A DZ970152A DZ2302A1 DZ 2302 A1 DZ2302 A1 DZ 2302A1 DZ 970152 A DZ970152 A DZ 970152A DZ 970152 A DZ970152 A DZ 970152A DZ 2302 A1 DZ2302 A1 DZ 2302A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical product
crystalline pharmaceutical
crystalline
product
pharmaceutical
Prior art date
Application number
DZ970152A
Other languages
English (en)
Inventor
Stephan Torey Ross
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DZ2302A1 publication Critical patent/DZ2302A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DZ970152A 1996-09-03 1997-09-02 Produit pharmaceutique cristallin. DZ2302A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2536996P 1996-09-03 1996-09-03

Publications (1)

Publication Number Publication Date
DZ2302A1 true DZ2302A1 (fr) 2002-12-28

Family

ID=21825633

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ970152A DZ2302A1 (fr) 1996-09-03 1997-09-02 Produit pharmaceutique cristallin.

Country Status (32)

Country Link
US (1) US6335330B1 (fr)
EP (1) EP0964684B1 (fr)
JP (1) JP2000517342A (fr)
CN (1) CN1102391C (fr)
AP (1) AP9901472A0 (fr)
AR (1) AR008154A1 (fr)
AT (1) ATE245984T1 (fr)
AU (1) AU731173B2 (fr)
BG (1) BG103196A (fr)
BR (1) BR9711981A (fr)
CA (1) CA2264607A1 (fr)
CO (1) CO4930262A1 (fr)
CZ (1) CZ71999A3 (fr)
DE (1) DE69723873T2 (fr)
DZ (1) DZ2302A1 (fr)
EA (1) EA001363B1 (fr)
ES (1) ES2205254T3 (fr)
HU (1) HUP9904077A3 (fr)
ID (1) ID18156A (fr)
IL (1) IL128782A0 (fr)
MA (1) MA24309A1 (fr)
MY (1) MY118175A (fr)
NO (1) NO991013D0 (fr)
NZ (1) NZ334438A (fr)
OA (1) OA10986A (fr)
PE (1) PE107198A1 (fr)
PL (1) PL332006A1 (fr)
SK (1) SK27699A3 (fr)
TR (1) TR199900480T2 (fr)
UY (1) UY24690A1 (fr)
WO (1) WO1998009629A1 (fr)
ZA (1) ZA977870B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19902529A1 (de) * 1999-01-22 2000-08-03 Goldwell Gmbh Haarbehandlungsmittel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
CN100560131C (zh) 2001-10-22 2009-11-18 斯克里普斯研究学院 抗体靶向化合物
US20050202151A1 (en) * 2004-03-15 2005-09-15 Land O'lakes, Inc. Method of preparing egg nuggets
KR101046977B1 (ko) * 2004-11-15 2011-07-07 삼성에스디아이 주식회사 카본나노튜브, 이를 포함한 전자 방출원 및 이를 구비한전자 방출 소자
US20070122408A1 (en) * 2005-10-20 2007-05-31 The Scripps Research Institute Fc Labeling for Immunostaining and Immunotargeting
US8518927B2 (en) 2009-02-10 2013-08-27 The Scripps Research Institute Chemically programmed vaccination

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD138319A1 (de) * 1978-08-08 1979-10-24 Helmut Roehnert Verfahren zur herstellung einer stabilen,kristallwasser-und kristalloesungsmittelfreien kristallform des 7-chlor-2-methylamino-5-phenyl-3h-1,4-benzodiazepin-4-oxid-hydrochlorids
ES2190428T3 (es) 1991-06-28 2003-08-01 Smithkline Beecham Corp Antagonistas biciclicos de fibrinogeno.
US5939412A (en) 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
DE69332860T2 (de) 1992-12-21 2004-03-11 Smithkline Beecham Corp. Bicyklische fibrinogen antagoniste
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.

Also Published As

Publication number Publication date
NO991013L (no) 1999-03-02
AR008154A1 (es) 1999-12-09
EP0964684A1 (fr) 1999-12-22
PL332006A1 (en) 1999-08-16
TR199900480T2 (xx) 1999-06-21
CN1102391C (zh) 2003-03-05
EP0964684B1 (fr) 2003-07-30
DE69723873T2 (de) 2004-04-22
MY118175A (en) 2004-09-30
EP0964684A4 (fr) 2002-05-29
HUP9904077A3 (en) 2002-03-28
AU4242597A (en) 1998-03-26
EA001363B1 (ru) 2001-02-26
JP2000517342A (ja) 2000-12-26
WO1998009629A1 (fr) 1998-03-12
EA199900260A1 (ru) 1999-08-26
US6335330B1 (en) 2002-01-01
CN1234739A (zh) 1999-11-10
CO4930262A1 (es) 2000-06-27
AP9901472A0 (en) 1999-03-31
CA2264607A1 (fr) 1998-03-12
BG103196A (en) 1999-09-30
ES2205254T3 (es) 2004-05-01
BR9711981A (pt) 1999-08-24
NZ334438A (en) 2000-10-27
OA10986A (en) 2003-03-04
HUP9904077A2 (hu) 2000-05-28
ID18156A (id) 1998-03-05
NO991013D0 (no) 1999-03-02
SK27699A3 (en) 2000-02-14
CZ71999A3 (cs) 1999-08-11
ATE245984T1 (de) 2003-08-15
ZA977870B (en) 1998-03-03
DE69723873D1 (de) 2003-09-04
PE107198A1 (es) 1999-03-21
MA24309A1 (fr) 1998-04-01
UY24690A1 (es) 1998-02-27
AU731173B2 (en) 2001-03-22
IL128782A0 (en) 2000-01-31

Similar Documents

Publication Publication Date Title
FI954402A0 (fi) Uusi farmaseuttinen tuote
MA24081A1 (fr) Produit alimentaire granulaire
FR2704458B1 (fr) Ensemble de distribution de produit.
DK0976075T3 (da) Produktudvælgelsessystem
DZ2516A1 (fr) Composition pharmaceutique en aérosol.
ATE284951T1 (de) Futtermittelprodukt
TR199600923A2 (tr) Sekerleme ürünü.
MA26785A1 (fr) Nouveau produit pharmaceutique.
BR9610214A (pt) Compostos farmacéuticos
DE69629671D1 (de) Netzbares produkt
MA26786A1 (fr) Nouveau produit pharmaceutique.
TR199600922A2 (tr) Cikolata ürünleri.
ZA961884B (en) Novel naphthyl pharmaceutical compounds.
DK0813586T3 (da) Mugfjernelsesprodukt
DZ2302A1 (fr) Produit pharmaceutique cristallin.
DZ1965A1 (fr) Composition pharmaceutique nouvelle.
MA26784A1 (fr) Nouveau produit pharmaceutique.
TR199601018A1 (tr) Farmasötik bilesikler.
DZ2159A1 (fr) Produits pharmaceutiques.
ITRM930227A0 (it) Procedimento migliorato per la preparazione di l-(-)-carnitina a partire da un prodotto di scarto avente opposta configurazione.
FR2726378B1 (fr) Produit radiographique
DE29615281U1 (de) Instantprodukt
FR2719223B1 (fr) Produit ophtalmologique.
UA1090S (uk) Фармацевтичний виріб
FR2706477B1 (fr) Produit de jointoiement.